Showing results (1321-1330 of 2,182) with videos related to
Sort By:
Pageof 219
Journal of Biopharmaceutical Statistics|February 26, 2010
Drug-drug interaction prediction assessmentJihao Zhou, Zhaohui Qin, Quinney K Sara, et al.Journal of Biopharmaceutical Statistics|February 26, 2010
Baseline observation carry forward: reasoning, properties, and practical issuesJun Shao, David C Jordan, Yili L PritchettJournal of Biopharmaceutical Statistics|February 26, 2010
A novel Gibbs maximum a posteriori (GMAP) approach on Bayesian nonlinear mixed-effects population pharmacokinetics (PK) modelsSeongho Kim, Stephen D Hall, Lang LiJournal of Biopharmaceutical Statistics|February 26, 2010
Parametric modeling of localized melanoma prognosis and outcomeShouluan Ding, Seng-Jaw Soong, Hui-Yi Lin, et al.Journal of Biopharmaceutical Statistics|February 26, 2010
Statistical methods to analyze adverse events data of randomized clinical trialsOhidul SiddiquiJournal of Biopharmaceutical Statistics|February 26, 2010
Addressing and advancing the problem of missing dataMarc K WaltonJournal of Biopharmaceutical Statistics|February 26, 2010
Missing inaction: preventing missing outcome data in randomized clinical trialsJanet WittesJournal of Biopharmaceutical Statistics|February 26, 2010
The impact of missing data in a generalized integer-valued autoregression model for count dataMohamed AloshJournal of Biopharmaceutical Statistics|February 26, 2010
An overview of practical approaches for handling missing data in clinical trialsCynthia M DeSouza, Anna T R Legedza, Abdul J SankohJournal of Biopharmaceutical Statistics|September 1, 1993
Planning survival studies to compare a treatment to an active controlD R BristolPageof 219